RECRUITING

Oxybutynin for Post-surgical Bladder Pain and Urgency

Talk to us

Conditions

Overactive Bladder SyndromeNeuropathic BladderTransdermal Oxybutynin

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.

Official Title

Oxybutynin for Post-surgical Bladder Pain and Urgency

Quick Facts

Study Start:2021-09-01
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03952299

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:4 Years to 8 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Patients who will undergo bladder surgery that requires an indwelling bladder catheter after surgery.
  2. * Age Range: Four to 8 years of age are eligible for the study.
  1. * Patients who have had prior bladder surgery.
  2. * Patients who have neurologic disease that could impair bladder sensation.
  3. * Patients who are already taking antimuscarinic or antispasmodic medications.
  4. * Patients with glaucoma, any neurologic disease, dementia, impaired mentation or disorder of the central nervous system.
  5. * Patients taking any medication that affects the central nervous system such as antidepressant, anxiolytic or antipsychotic medications.
  6. * Less than four years of age cannot have the transdermal patch due to fixed dose. Over 8 years of age: less than 5% of our patients, who undergo this surgery, are over 8 years of age and is usually a rare adolescent. Data in an older cohort may confuse the results since they respond differently to bladder surgery due to larger incision and longer hospital stay with a catheter.

Contacts and Locations

Study Contact

Anjali Vij, BS
CONTACT
9167345173
avij@ucdavis.edu

Principal Investigator

Eric A Kurzrock, MD
PRINCIPAL_INVESTIGATOR
UC Davis Health Center

Study Locations (Sites)

University of California Davis Medical Center (UCDMC)
Sacramento, California, 95817
United States

Collaborators and Investigators

Sponsor: University of California, Davis

  • Eric A Kurzrock, MD, PRINCIPAL_INVESTIGATOR, UC Davis Health Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-09-01
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2021-09-01
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Transdermal Oxybutynin

Additional Relevant MeSH Terms

  • Overactive Bladder Syndrome
  • Neuropathic Bladder